Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Larsen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Opinion in Biotechnology|April 1, 1991
Thrombolytic therapy with tissue-type plasminogen activator: new modes and novel variant plasminogen activatorsG R Larsen, E S Barnathan
The Journal of Biological Chemistry|January 15, 1988
Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domainsG R Larsen, K Henson, Y Blue
The Journal of Biological Chemistry|December 15, 1990
The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrinM Nesheim, J C Fredenburgh, G R Larsen
Journal of Virology|January 1, 1981
Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNAG R Larsen, B L Semler, E Wimmer
Blood|May 15, 1989
Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in ratG R Larsen, M Metzger, K Henson, et al.
Journal of Cardiovascular Pharmacology|April 1, 1988
Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosisP Cambier, F van de Werf, G R Larsen, et al.
The Journal of Biological Chemistry|October 25, 1988
Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activatorL Hansen, Y Blue, K Barone, et al.
Nucleic Acids Research|March 25, 1980
The structure of poliovirus replicative formG R Larsen, A J Dorner, T J Harris, et al.
Journal of Virology|June 1, 1982
Identification of the initiation site of poliovirus polyprotein synthesisA J Dorner, L F Dorner, G R Larsen, et al.
Journal of Virology|September 1, 1982
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodiesE A Emini, B A Jameson, A J Lewis, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|April 1, 1991
Thrombolytic therapy with tissue-type plasminogen activator: new modes and novel variant plasminogen activatorsG R Larsen, E S Barnathan
The Journal of Biological Chemistry|January 15, 1988
Variants of human tissue-type plasminogen activator. Fibrin binding, fibrinolytic, and fibrinogenolytic characterization of genetic variants lacking the fibronectin finger-like and/or the epidermal growth factor domainsG R Larsen, K Henson, Y Blue
The Journal of Biological Chemistry|December 15, 1990
The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrinM Nesheim, J C Fredenburgh, G R Larsen
Journal of Virology|January 1, 1981
Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNAG R Larsen, B L Semler, E Wimmer
Blood|May 15, 1989
Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in ratG R Larsen, M Metzger, K Henson, et al.
Journal of Cardiovascular Pharmacology|April 1, 1988
Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosisP Cambier, F van de Werf, G R Larsen, et al.
The Journal of Biological Chemistry|October 25, 1988
Functional effects of asparagine-linked oligosaccharide on natural and variant human tissue-type plasminogen activatorL Hansen, Y Blue, K Barone, et al.
Nucleic Acids Research|March 25, 1980
The structure of poliovirus replicative formG R Larsen, A J Dorner, T J Harris, et al.
Journal of Virology|June 1, 1982
Identification of the initiation site of poliovirus polyprotein synthesisA J Dorner, L F Dorner, G R Larsen, et al.
Journal of Virology|September 1, 1982
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodiesE A Emini, B A Jameson, A J Lewis, et al.
Pageof 2